Wolverine Asset Management LLC purchased a new stake in Danimer Scientific, Inc. (NYSE:DNMR – Get Rating) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 18,146 shares of the company’s stock, valued at approximately $106,000.
Several other hedge funds have also added to or reduced their stakes in the company. Ensign Peak Advisors Inc bought a new position in Danimer Scientific during the fourth quarter worth about $242,000. Exos Asset Management LLC boosted its holdings in Danimer Scientific by 83.1% during the first quarter. Exos Asset Management LLC now owns 22,117 shares of the company’s stock worth $130,000 after buying an additional 10,038 shares during the last quarter. Heathbridge Capital Management Ltd. boosted its holdings in Danimer Scientific by 29.5% during the fourth quarter. Heathbridge Capital Management Ltd. now owns 1,456,640 shares of the company’s stock worth $12,411,000 after buying an additional 331,750 shares during the last quarter. Forum Financial Management LP bought a new position in Danimer Scientific during the fourth quarter worth about $7,384,000. Finally, Camden Capital LLC boosted its holdings in Danimer Scientific by 20.9% during the fourth quarter. Camden Capital LLC now owns 64,682 shares of the company’s stock worth $551,000 after buying an additional 11,200 shares during the last quarter. Institutional investors own 51.47% of the company’s stock.
In other news, CMO Scott Tuten sold 10,000 shares of Danimer Scientific stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $5.08, for a total transaction of $50,800.00. Following the transaction, the chief marketing officer now owns 474,136 shares in the company, valued at approximately $2,408,610.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 14.60% of the stock is currently owned by company insiders.
Danimer Scientific Price Performance
Danimer Scientific (NYSE:DNMR – Get Rating) last issued its earnings results on Tuesday, May 10th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.03. Danimer Scientific had a negative return on equity of 14.35% and a net margin of 13.66%. The firm had revenue of $14.74 million for the quarter. During the same quarter last year, the business posted ($0.14) EPS. On average, equities analysts predict that Danimer Scientific, Inc. will post -0.95 earnings per share for the current year.
Danimer Scientific Profile
Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.
- Get a free copy of the StockNews.com research report on Danimer Scientific (DNMR)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn’t Ignore
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.